跳到內容

跳到副選單

耶和華見證人

中文繁體(國語)

輸血替代療法的效益

經濟效益評估

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals.

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL

出處‎: Transfusion 2017;57(6):1347-58.

檢索‎: PubMed 28150313

DOI碼‎: 10.1111/trf.14006

http://www.ncbi.nlm.nih.gov/pubmed/28150313

Contemporary economics of transfusions.

Hannon TJ, Paulson-Gjerde K.

出處‎: Perioperative Transfusion Medicine. Second edition. Philadelphia, Penn, USA: Lippincott Williams & Wilkins; 2006. p. 13-38.

檢索‎: ISBN 0-7817-3755-9

http://www.worldcat.org/oclc/62123297

Risk-adjusted clinical outcomes in patients enrolled in a bloodless program.

Frank SM, Wick EC, Dezern AE, Ness PM, Wasey JO, Pippa AC, Dackiw E, Resar LMS.

出處‎: Transfusion 2014;54(10 Pt 2):2668-77.

檢索‎: PubMed 24942198

DOI碼‎: 10.1111/trf.12752

http://www.ncbi.nlm.nih.gov/pubmed/24942198

The ONTraC Ontario program in blood conservation.

Freedman J.

出處‎: Transfus Apher Sci 2014;50(1):32-6.

檢索‎: PubMed 24388485

DOI碼‎: 10.1016/j.transci.2013.12.010

http://www.ncbi.nlm.nih.gov/pubmed/24388485

Effective reduction of blood product use in a community teaching hospital: when less is more.

Politsmakher A, Doddapaneni V, Seeratan R, Dosik H.

出處‎: Am J Med 2013;126(10):894-902.

檢索‎: PubMed 24054957

DOI碼‎: 10.1016/j.amjmed.2013.06.013

http://www.ncbi.nlm.nih.gov/pubmed/24054957

Economic considerations on transfusion medicine and patient blood management.

Hofmann A, Ozawa S, Farrugia A, Farmer SL, Shander A.

出處‎: Best Pract Res Clin Anaesthesiol 2013;27(1):59-68.

檢索‎: PubMed 23590916

DOI碼‎: 10.1016/j.bpa.2013.02.001

http://www.ncbi.nlm.nih.gov/pubmed/23590916

Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients.

Stokes ME, Ye X, Shah M, Mercaldi K, Reynolds MW, Rupnow MF, Hammond J.

出處‎: BMC Health Serv Res 2011;11:135.

檢索‎: PubMed 21627788

DOI碼‎: 10.1186/1472-6963-11-135

http://www.ncbi.nlm.nih.gov/pubmed/21627788

Frequency and outcomes of blood products transfusion across procedures and clinical conditions warranting inpatient care: an analysis of the 2004 healthcare cost and utilization project nationwide inpatient sample database.

Morton J, Anastassopoulos KP, Patel ST, Lerner JH, Ryan KJ, Goss TF, Dodd SL.

出處‎: Am J Med Qual 2010;25(4):289-96.

檢索‎: PubMed 20530223

DOI碼‎: 10.1177/1062860610366159

http://www.ncbi.nlm.nih.gov/pubmed/20530223

Activity-based costs of blood transfusions in surgical patients at four hospitals.

Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR.

出處‎: Transfusion 2010;50(4):753-65.

檢索‎: PubMed 20003061

DOI碼‎: 10.1111/j.1537-2995.2009.02518.x

http://www.ncbi.nlm.nih.gov/pubmed/20003061

Blood management: a primer for clinicians.

Boucher BA, Hannon TJ.

出處‎: Pharmacotherapy 2007;27(10):1394-411.

檢索‎: PubMed 17896895

http://www.ncbi.nlm.nih.gov/pubmed/17896895

Risks, benefits, alternatives and indications of allogenic blood transfusions.

Madjdpour C, Heindl V, Spahn DR.

出處‎: Minerva Anestesiol 2006;72(5):283-98.

檢索‎: PubMed 16675937

http://www.ncbi.nlm.nih.gov/pubmed/16675937


JW.ORG​網站​內​的​醫療​資訊​主要​是​提供​給​醫生​及​醫療人員​參考,而​不​是​要​提供​診斷​建議​或​推薦​某​種​醫療​方法,也​不​是​要​取代​專業​的​醫療​護理。網站​上​引用​的​許多​醫學​文章​都​不​是​耶和華見證人​出版​的,但​當​中​提​到​了​許多​替代​輸​血​的​療法,這些​醫療​策略​很​值得​醫生​參考。每​一​個​專業​醫療人員​都​有​責任​經常​吸收​最​新​的​醫療​資訊,討論​最​適合​病人​的​醫療​方法。他們​也​要​根據​病人​的​病情、意願、價值觀​和​信仰​來​協助​病人​選擇​最佳​的​醫療​方式。本​網站​所​提供​的​醫療​策略​不​一定​適用​於​每​一​個​病人。

給​病人​的​建議:當​你​感到​身體​不適,要​立刻​尋求​醫生​的​幫助,也​要​聽取​醫生​以及​其他​專業​醫療人員​的​建議。

使用​本​網站​即​表示​你​接受​本使用​條款的​全部​內容。